Trastuzumab Injection 440 mg With Wfi Uses
Trastuzumab is a targeted therapy used primarily in the treatment of certain types of breast cancer and gastric cancer that overexpress the HER2 protein. It is often prescribed for HER2-positive early-stage breast cancer, metastatic breast cancer, and metastatic gastric cancer. This medicine is used in combination with chemotherapy or as a single agent depending on the stage and type of cancer.
How Trastuzumab works
Trastuzumab is a monoclonal antibody that binds to the HER2 receptor on cancer cells. By attaching to these receptors, it blocks growth signals, slows cancer cell proliferation, and helps the immune system destroy the cancer cells. This targeted approach makes it effective specifically for HER2-positive cancers.
Common side effects of Trastuzumab
- Infusion-related reactions (fever, chills, nausea, headache)
- Diarrhea
- Fatigue
- Weakness
- Heart problems (reduced heart function, heart failure) – requires regular monitoring
- Low blood cell counts (neutropenia, anemia)
- Infections
- Rash
Expert advice for Trastuzumab
- Trastuzumab is given as an intravenous infusion, typically once every 1 to 3 weeks, under medical supervision.
- Your doctor will monitor your heart function (echocardiogram or MUGA scan) before and during treatment because Trastuzumab can weaken the heart muscle.
- Inform your doctor if you have any pre-existing heart conditions, high blood pressure, or are pregnant or breastfeeding.
- Do not stop or change the dose without consulting your oncologist.
- Report any signs of infection, unusual bleeding, or shortness of breath immediately.
Jan Aushadhi price and availability
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), Trastuzumab Injection 440 mg with WFI is available at a significantly reduced price of ₹14,062.50 per vial, compared to branded versions which can cost several times more. This makes HER2-targeted therapy more affordable for patients. The medicine is available at Jan Aushadhi Kendras across India. Always verify the batch and expiry date at the time of purchase.
Safety note
This information is for educational purposes only and does not replace professional medical advice. Trastuzumab is a prescription-only medicine and must be used under the supervision of a qualified oncologist. Do not self-administer or share this medicine. Always consult your doctor for the correct dosage, treatment schedule, and monitoring plan.